abstract |
The present invention involves compounds as PPAR agonists and applications thereof. The compounds involved are novel peroxisome proliferator-activated receptor (PPAR) γ receptor agonists and can inhibit the production of mitochondrial reactive oxygen species. Most of the compounds can cross the blood-brain barrier. Also provided are pharmaceutical uses of the compounds. |